Abstract
Background
Acute kidney injury is seen in approximately 30% of patients with severe alcohol-associated hepatitis (AH) and is associated with increased mortality. Controversy exists surrounding initiation of renal replacement therapy (RRT) in these patients, as most are ineligible for early transplantation.
Aims
The primary aim was to identify predictors of survival and identify patients who may benefit from RRT as a bridge to transplant or recovery.
Methods
A retrospective multicenter cohort of adult patients with AH, who received RRT, was developed, including patients from two North American and one European liver transplant centers.
Results
Fifty-five patients were included. Survival was 26/55 (47.3%) at 30 days, 17/55 (30.9%) at 3 months, and 15/55 (27.2%) at 6 months. Of those who survived 6 months, 2/15 (13.3%) received simultaneous liver and kidney transplantation, 11/15 (73.3%) had spontaneous recovery of kidney function, and 2/15 (13.3%) remained on RRT. Of patients who survived at least 3 months, 8/17 (47%) completed addiction treatment. Predictors of mortality were pre-RRT MELD (OR 1.10, 1.02–1.19) and pre-RRT MELD-Na (OR 1.14, 1.03–1.27). Pre-RRT MELD-Na < 35 was associated with lower 6-month mortality (OR 0.23, 0.06 – 0.81). Of patients with pre-RRT MELD-Na < 35, 50% survived 6 months compared to 18% of patients with pre-RRT MELD-Na ≥ 35.
Conclusions
Although RRT has a limited role in patients with decompensated cirrhosis, ineligible for transplant, it may be used in select patients with AH. This may allow for spontaneous recovery with alcohol abstinence or completion of addiction treatment prior to transplant.
Similar content being viewed by others
Abbreviations
- AKI:
-
Acute kidney injury
- AH:
-
Alcohol-associated hepatitis
- RRT:
-
Renal replacement therapy,
- NIAAA:
-
National Institute of Alcohol Abuse and Alcoholism
- HRS-AKI:
-
Hepatorenal syndrome-acute kidney injury
- MELD:
-
Model for End-Stage Liver Disease
- MELD-Na:
-
Model for End-Stage Liver Disease-Sodium
- SD:
-
Standard deviation
- OR:
-
Odds ratio
- CI:
-
Confidence interval
- ATN:
-
Acute tubular necrosis
- HE:
-
Hepatic encephalopathy
References
Altamirano J, Fagundes C, Dominguez M, García E, Michelena J, Cárdenas A et al. Acute Kidney Injury Is an Early Predictor of Mortality for Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2012;10:65–71.e3
Maiwall R, Chandel SS, Wani Z, Kumar S, Sarin SK. SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis. Dig Dis Sci. 2016;61:920–929. https://doi.org/10.1007/s10620-015-3921-4
Sujan R, Cruz-Lemini M, Altamirano J, Simonetto DA, Maiwall R, Axley P et al. A Validated Score Predicts Acute Kidney Injury and Survival in Patients With Alcoholic Hepatitis. Liver Transplant. 2018;24:1655–1664
Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N et al. Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care. 2012;16:R23
Wong LP, Blackley MP, Andreoni KA, Chin H, Falk RJ, Klemmer PJ. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int. 2005;68:362–370
Capling RK, Bastani B. The Clinical Course of Patients with Type 1 Hepatorenal Syndrome Maintained on Hemodialysis. Renal Fail. 2004;26:563–568
Wong F, Leung W, Al Beshir M, Marquez M, Renner EL. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation. Liver Transplant. 2015;21:300–307
Bangaru S, Pedersen MR, MacConmara MP, Singal AG, Mufti AR. Survey of Liver Transplantation Practices for Severe Acute Alcoholic Hepatitis. Liver Transplant. 2018;24:1357–1362
Hasanin M, Dubay DA, McGuire BM, Schiano T, Singal AK. Liver transplantation for alcoholic hepatitis: A survey of liver transplant centers. Liver Transplant. 2015;21:1449–1452
Asrani SK, Trotter J, Lake J, Ahmed A, Bonagura A, Cameron A, et al. Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis. Liver Transplant. 2020;26:127–40.
Angeli P, Ginès P, Wong F, Bernardi M, Boyer TD, Gerbes A et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62:968–974
Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P et al. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016;150:785–790
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470
Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797–805
Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT et al. Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List. New England J Med. 2008;359:1018–1026
Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP et al. Prednisolone or Pentoxifylline for Alcoholic Hepatitis. New England J Med. 2015;372:1619–1628
Peeraphatdit T, Kamath PS, Karpyak VM, Davis B, Desai V, Liangpunsakul S et al. Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2020;18:477–85.e5
Allegretti AS, Parada XV, Eneanya ND, Gilligan H, Xu D, Zhao S et al. Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT. Clin J Am Soc Nephrol. 2018;13:16–25
Lenhart A, Hussain S, Salgia R. Chances of Renal Recovery or Liver Transplantation After Hospitalization for Alcoholic Liver Disease Requiring Dialysis. Dig Dis Sci. 2018;63:2800–2809. https://doi.org/10.1007/s10620-018-5170-9
Watt K, Uhanova J, Minuk GY. Hepatorenal Syndrome: Diagnostic Accuracy, Clinical Features, and Outcome in A Tertiary Care Center. Am J Gastroenterol. 2002;97:2046–2050
Ginès P, Solà E, Angeli P, Wong F, Nadim MK, Kamath PS. Hepatorenal syndrome. Nature Rev Disease Primers. 2018;4:23
Belcher JM, Sanyal AJ, Peixoto AJ, Perazella MA, Lim J, Thiessen-Philbrook H et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology (Baltimore, Md). 2014;60:622–632
Huelin P, Solà E, Elia C, Solé C, Risso A, Moreira R, et al. Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study. 2019;70:319-33
Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–460
Altamirano J, Higuera-de laTijera F, Duarte-Rojo A, Martínez-Vázquez MA, Abraldes JG, Herrera-Jiménez LE, et al. The Amount of Alcohol Consumption Negatively Impacts Short-Term Mortality in Mexican Patients With Alcoholic Hepatitis. Am J Gastroenterol. 2011;106.
Altamirano J, Miquel R, Katoonizadeh A, Abraldes JG, Duarte-Rojo A, Louvet A, et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014;146:1231-9 e1-6.
Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113:175–194
Funding
There was no financial support. There were no grants to report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
A.A. has served on the advisory board for Mallinckrodt Pharmaceutics. V.S. serves on the Advisory Board for Akaza Bioscience Ltd., Generon Shanghai, and Surrozen; he provides consulting services for Ambys Medicines and Durect Corporation. The other authors declare that there are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
See Table 4
Rights and permissions
About this article
Cite this article
Jones, B.E., Allegretti, A.S., Pose, E. et al. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery. Dig Dis Sci 67, 697–707 (2022). https://doi.org/10.1007/s10620-021-06864-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-021-06864-z